semaglutide and crohn's disease GLP-1 Disease: Safety Guide How Crohn's Is Linked – Can You Take Weight Loss

If you are considering a GLP-1 medication in the postpartum period, here are some important things to know

Therapeutic potential of hydrogen sulfide in reproductive system disorders

Haddad, G., Dylewski, J., Evans, R., Lewis, L

According to FDA labeling, the common side effects include: Gastrointestinal effects (with frequencies varying by dose): Nausea (12-30% of patients, often most prominent during dose escalation) Diarrhea (7-22%) Vomiting (2-10%) Constipation (5-17%) Abdominal pain or discomfort (5-10%) Decreased appetite (5-10%) Dyspepsia/indigestion (2-9%) Gastroesophageal reflux disease (1-5%, more common in weight management indication) Eructation/belching (more common in weight management indication) These gastrointestinal symptoms typically occur early in treatment or following dose increases and often diminish over time as the body adjusts to the medication